Science Explorer Back to mapMap
Discussion
Researcher · Leo Pharma (Denmark) · Denmark

Mads Almose Røpke

Mads Almose Røpke publishes mostly in Dermatology, Immunology and Immunology and Allergy, on topics such as Dermatology and Skin Diseases, Psoriasis: Treatment and Pathogenesis and Allergic Rhinitis and Sensitization.

ORCID 0000-0001-8922-5430 OpenAlex
World rank
#1,845,428
of 7,710,434 ranked researchers
Rank in Denmark
#13,955
of 43,819
Works
61
Citations
1.5k
Citations per work
24.3
h-index
19
i10-index 31Top 18% in Dermatology
Mads Almose Røpke

What does Mads Almose Røpke research?

Mads Almose Røpke's work is mostly in Medicine (42%), Immunology and Microbiology (24%), Biochemistry, Genetics and Molecular Biology (7%).

Health Sciences: 25 works · 41.7% of their workMedicine: 25 works · 41.7% of their workDermatology: 15 works · 24.7% of their workImmunology and Allergy: 5 works · 7.6% of their workRheumatology: 3 works · 5.3% of their workPhysiology: 3 works · 4.1% of their workLife Sciences: 18 works · 30.0% of their workImmunology and Microbiology: 14 works · 23.5% of their workImmunology: 14 works · 23.5% of their workBiochemistry, Genetics and Molecular Biology: 4 works · 6.5% of their workMolecular Biology: 4 works · 6.5% of their workEverything else: 17 works · 28.3% of their workTHEIR WORKMads Almose Røpke61works
Life Sciences30%Health Sciences42%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine2541.7%
    1. Immunology and Microbiology1423.5%
    2. Biochemistry, Genetics and Molecular Biology46.5%
  3. Everything else1728.3%
  1. 1Dermatology25% of their works
  2. 2Immunology24% of their works
  3. 3Immunology and Allergy8% of their works
  4. 4Molecular Biology6% of their works
  5. 5Rheumatology5% of their works
  6. 6Physiology4% of their works

Research topics

Which keywords describe Mads Almose Røpke's research?

The keywords of their largest research topics: Filaggrin, Skin Microbiome, Regulatory T Cells, Asthma, Epidemiology, IL-17, TH17 Cells and Allergen-specific Immunotherapy.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Filaggrin311 topic
  2. Skin Microbiome311 topic
  3. Regulatory T Cells192 topics
  4. Asthma162 topics
  5. Epidemiology162 topics
  6. IL-17131 topic
  7. TH17 Cells131 topic
  8. Allergen-specific Immunotherapy91 topic
  9. Pollen Allergy91 topic
  10. Allergic Diseases71 topic
  11. Eosinophils71 topic
  12. Dendritic Cells61 topic
  13. IL-3361 topic
  14. Immunity61 topic
  15. Innate Lymphoid Cells61 topic
  16. Microneedles61 topic
  17. Solid Lipid Nanoparticles61 topic
  18. NK Cell Recognition51 topic
  19. Natural Killer Cells51 topic

Where does Mads Almose Røpke work?

Mads Almose Røpke's main affiliation in the publication record is Leo Pharma (Denmark), Denmark.

How many publications and citations does Mads Almose Røpke have?

OpenAlex counts 61 works and 1,484 citations for Mads Almose Røpke, an h-index of 19, ranking #1,845,428 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Mads Almose Røpke. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.